Skip to main content
Clinical Trials/NCT05948527
NCT05948527CompletedNot Applicable

Safety and Efficacy of High Flow Nasal Canula in Patients With Mild Hypercapnia

Mansoura University1 site in 1 country30 target enrollmentStarted: January 1, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
30
Locations
1
Primary Endpoint
Arterial Blood Gases changes

Study Overview

Brief Summary

Evaluate safety and efficacy of application ( high flow nasal canula) in cases with mild hypercapnia, included 30 patients who were hospitalized in Mansoura University chest department with mild Hypercapnia (Pco2 range 45-60 mmhg and power of hydrogen not less 7.30) of different pulmonary disease categories (Chronic obstructive pulmonary disease acute exacerbation, pneumonia, Interstitial lung diseases, etc).

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •patients with mild Hypercapnia

Exclusion Criteria

  • •Excluded cases had age less than 18 years or pediatric group .
  • •patients with their mental state altered, confused, comatose, severe agitation or non cooperative
  • •Cases with moderate or severe Hypercapnia
  • •cases in need for immediate invasive mechanical ventilation
  • •cases with respiratory rate more than 35 breath per minute.
  • •cases with Respiratory exhaustion , fatigue , excess use of respiratory accessory muscles
  • •Shock , hemodynamic instability, post arrest cases,
  • •cases with facial trauma or severe nasal deformity,
  • •Patients with sleep breathing disorders or upper airway obstruction
  • •patients with history of home ventilation prior admission

Arms & Interventions

with mild Hypercapnia (Pco2 range 45-60 mmhg and power of hydrogen not less 7.30)

Experimental

with mild Hypercapnia (Pco2 range 45-60 mmhg and power of hydrogen not less 7.30) of different pulmonary disorders

Intervention: high flow nasal canula (Device)

Outcomes

Primary Outcomes

Arterial Blood Gases changes

Time Frame: 48 hours

The primary outcome was concerned about changes in Arterial Blood Gases in first 24 h after admission and the same changes 48 h after admission.

Secondary Outcomes

  • Number of participants in need for ventilation(7 days)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials